LIGAND PHARMACEUTICALS INCORPORATED Deferred Revenue
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Deferred Revenue of $75.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-05-09
- 2018-03-31: Deferred Revenue, Current $75.00K.
- 2017-12-31: Deferred Revenue, Current $173.00K.
- 2017-09-30: Deferred Revenue, Current $1.07M.
- 2016-12-31: Deferred Revenue, Current $0.00.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2018-03-31 | $75.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $173.00K 10-Q · filed 2018-05-09 | |
| 2017-09-30 | $1.07M 10-Q · filed 2017-11-09 | |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-09 | |
| 2015-09-30 | $34.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $300.00K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $67.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.06M 10-Q · filed 2015-11-09 | $116.00K 10-K · filed 2014-12-01 |
| 2014-09-30 | $114.00K 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $92.00K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $116.00K 10-K · filed 2015-02-23 | |
| 2013-09-30 | $336.00K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $452.00K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $556.00K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $486.00K 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $458.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $412.00K 10-Q/A · filed 2012-11-14 | |
| 2012-03-31 | $727.00K 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $1.24M 10-K · filed 2013-03-14 | |
| 2011-06-30 | $38.00K 10-Q/A · filed 2012-02-10 | |
| 2010-12-31 | $0.00 10-Q/A · filed 2012-02-10 |